Helix 1/8 interactions influence the activity of nuclear receptor ligand-binding domains

被引:10
作者
Holt, JA [1 ]
Consiler, TG [1 ]
Williams, SP [1 ]
Ayscue, AH [1 ]
Leesnitzer, LM [1 ]
Wisely, GB [1 ]
Billin, AN [1 ]
机构
[1] GlaxoSmithKline Res & Dev, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1210/me.2003-0001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ligand-binding domain (LBD) of apo-nuclear receptors in solution is thought to be a very dynamic structure with many possible conformations. Upon ligand binding, the structure is stabilized to a more rigid conformation. The dynamic stabilization assay is a LBD reassembly assay that takes advantage of the high specificity of the intramolecular interactions that comprise the ligand-bound LBD. Here, we demonstrate dynamic stabilization for the nuclear receptors peroxisome proliferator-activated receptor (PPAR)gamma and nerve growth factor inducible (NGFIB)beta and identify residues important for stabilization of the intramolecular interactions induced by PPARgamma ligands. Site-directed mutagenesis studies identified residues in helices 1 and 8 required for LBD reassembly. Further, disrupting the helix 1/8 interaction in the context of the holo-LBD alters the response of the receptor in a compound-specific manner, suggesting that residues far from the ligand-binding pocket can influence the stability of the ligand-bound receptor. Thus, these results support and extend models of the apo-LBD of PPARgamma as a dynamic structure.
引用
收藏
页码:1704 / 1714
页数:11
相关论文
共 29 条
[1]   COMPARISON OF THE PHYSICOCHEMICAL PROPERTIES OF UTERINE NUCLEAR ESTROGEN-RECEPTORS BOUND TO ESTRADIOL OR 4-HYDROXYTAMOXIFEN [J].
ATTARDI, B ;
HAPPE, HK .
ENDOCRINOLOGY, 1986, 119 (02) :904-915
[2]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[3]   Solution structure of the interacting domains of the Mad-Sin3 complex: Implications for recruitment of a chromatin-modifying complex [J].
Brubaker, K ;
Cowley, SM ;
Huang, K ;
Loo, L ;
Yochum, GS ;
Ayer, DE ;
Eisenman, RN ;
Radhakrishnan, I .
CELL, 2000, 103 (04) :655-665
[4]   Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870
[5]   Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure [J].
Couette, B ;
Fagart, J ;
Jalaguier, S ;
Lombes, M ;
Souque, A ;
RafestinOblin, ME .
BIOCHEMICAL JOURNAL, 1996, 315 :421-427
[6]   Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family [J].
Cronet, P ;
Petersen, JFW ;
Folmer, R ;
Blomberg, N ;
Sjöblom, K ;
Karlsson, U ;
Lindstedt, EL ;
Bamberg, K .
STRUCTURE, 2001, 9 (08) :699-706
[7]   Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand:: 9-cis retinoic acid [J].
Egea, PF ;
Mitschler, A ;
Rochel, N ;
Ruff, M ;
Chambon, P ;
Moras, D .
EMBO JOURNAL, 2000, 19 (11) :2592-2601
[8]   A 13-amino acid amphipathic α-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A [J].
Eilers, AL ;
Billin, AN ;
Liu, J ;
Ayer, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :32750-32756
[9]   Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors [J].
Gampe, RT ;
Montana, VG ;
Lambert, MH ;
Miller, AB ;
Bledsoe, RK ;
Milburn, MV ;
Kliewer, SA ;
Willson, TM ;
Xu, HE .
MOLECULAR CELL, 2000, 5 (03) :545-555
[10]   Increase in the stability and helical content of estrogen receptor a in the presence of the estrogen response element: Analysis by circular dichroism spectroscopy [J].
Greenfield, N ;
Vijayanathan, V ;
Thomas, TJ ;
Gallo, MA ;
Thomas, T .
BIOCHEMISTRY, 2001, 40 (22) :6646-6652